$HBIO
HARVARD BIOSCIENCE INC

2011 Q2 Form 10-Q Financial Statement

#000119312511216296 Filed on August 09, 2011

View on sec.gov

Income Statement

Concept 2011 Q2 2010 Q2
Revenue $27.14M $25.91M
YoY Change 4.78% 43.52%
Cost Of Revenue $14.36M $13.86M
YoY Change 3.63% 52.09%
Gross Profit $12.79M $12.05M
YoY Change 6.1% 34.79%
Gross Profit Margin 47.1% 46.52%
Selling, General & Admin $8.477M $7.998M
YoY Change 5.99% 28.17%
% of Gross Profit 66.3% 66.37%
Research & Development $1.128M $1.102M
YoY Change 2.36% 1.1%
% of Gross Profit 8.82% 9.15%
Depreciation & Amortization $1.100M $960.0K
YoY Change 14.58% 20.0%
% of Gross Profit 8.6% 7.97%
Operating Expenses $10.27M $9.678M
YoY Change 6.08% 25.53%
Operating Profit $2.519M $2.372M
YoY Change 6.2% 92.85%
Interest Expense $192.0K $129.0K
YoY Change 48.84% -132.25%
% of Operating Profit 7.62% 5.44%
Other Income/Expense, Net -$519.0K $125.0K
YoY Change -515.2% -308.33%
Pretax Income $2.000M $2.497M
YoY Change -19.9% 613.43%
Income Tax $630.0K $615.0K
% Of Pretax Income 31.5% 24.63%
Net Earnings $1.370M $1.882M
YoY Change -27.21% 572.14%
Net Earnings / Revenue 5.05% 7.27%
Basic Earnings Per Share $0.05 $0.06
Diluted Earnings Per Share $0.05 $0.06
COMMON SHARES
Basic Shares Outstanding 28.43M shares 29.58M shares
Diluted Shares Outstanding 30.19M shares 30.04M shares

Balance Sheet

Concept 2011 Q2 2010 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.70M $15.70M
YoY Change 38.22% -6.55%
Cash & Equivalents $21.75M $15.72M
Short-Term Investments
Other Short-Term Assets $2.448M $600.0K
YoY Change 308.0% 100.0%
Inventory $19.01M $14.60M
Prepaid Expenses
Receivables $14.46M $13.90M
Other Receivables $2.400M $2.400M
Total Short-Term Assets $62.88M $47.20M
YoY Change 33.22% 7.03%
LONG-TERM ASSETS
Property, Plant & Equipment $3.438M $3.200M
YoY Change 7.44% -5.88%
Goodwill $34.07M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $286.0K $800.0K
YoY Change -64.25% 0.0%
Total Long-Term Assets $66.13M $55.70M
YoY Change 18.73% 44.68%
TOTAL ASSETS
Total Short-Term Assets $62.88M $47.20M
Total Long-Term Assets $66.13M $55.70M
Total Assets $129.0M $102.9M
YoY Change 25.37% 24.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.367M $4.900M
YoY Change 9.53% 44.12%
Accrued Expenses $3.646M $3.200M
YoY Change 13.94% -17.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.34M $10.20M
YoY Change 1.41% 10.87%
LONG-TERM LIABILITIES
Long-Term Debt $17.11M $11.20M
YoY Change 52.74%
Other Long-Term Liabilities $3.700M $3.900M
YoY Change -5.13% 77.27%
Total Long-Term Liabilities $17.11M $15.10M
YoY Change 13.29% 586.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.34M $10.20M
Total Long-Term Liabilities $17.11M $15.10M
Total Liabilities $32.20M $27.40M
YoY Change 17.52% 117.46%
SHAREHOLDERS EQUITY
Retained Earnings -$80.40M
YoY Change
Common Stock $189.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 7.746M shares
Shareholders Equity $96.81M $75.50M
YoY Change
Total Liabilities & Shareholders Equity $129.0M $102.9M
YoY Change 25.37% 24.58%

Cashflow Statement

Concept 2011 Q2 2010 Q2
OPERATING ACTIVITIES
Net Income $1.370M $1.882M
YoY Change -27.21% 572.14%
Depreciation, Depletion And Amortization $1.100M $960.0K
YoY Change 14.58% 20.0%
Cash From Operating Activities $1.660M $3.080M
YoY Change -46.1% 26.75%
INVESTING ACTIVITIES
Capital Expenditures -$440.0K -$270.0K
YoY Change 62.96% -27.03%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.460M
YoY Change -100.0%
Cash From Investing Activities -$440.0K -$1.730M
YoY Change -74.57% 367.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 330.0K -2.220M
YoY Change -114.86% 42.31%
NET CHANGE
Cash From Operating Activities 1.660M 3.080M
Cash From Investing Activities -440.0K -1.730M
Cash From Financing Activities 330.0K -2.220M
Net Change In Cash 1.550M -870.0K
YoY Change -278.16% -274.0%
FREE CASH FLOW
Cash From Operating Activities $1.660M $3.080M
Capital Expenditures -$440.0K -$270.0K
Free Cash Flow $2.100M $3.350M
YoY Change -37.31% 19.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Document Period End Date
DocumentPeriodEndDate
2011-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-11
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2011Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28489100 shares
CY2011Q3 dei Entity Public Float
EntityPublicFloat
148713102 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001123494
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21747000 USD
CY2011Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14458000 USD
CY2011Q2 us-gaap Inventory Net
InventoryNet
19005000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5222000 USD
CY2011Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2448000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
62880000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3438000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6175000 USD
CY2011Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20864000 USD
CY2011Q2 us-gaap Goodwill
Goodwill
34065000 USD
CY2011Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1302000 USD
CY2011Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
286000 USD
CY2011Q2 us-gaap Assets
Assets
129010000 USD
CY2011Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5367000 USD
CY2011Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
497000 USD
CY2011Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
516000 USD
CY2011Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3646000 USD
CY2011Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
318000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10344000 USD
CY2011Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17107000 USD
CY2011Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1023000 USD
CY2011Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3727000 USD
CY2011Q2 us-gaap Liabilities
Liabilities
32201000 USD
us-gaap Commitments And Contingencies2009
CommitmentsAndContingencies2009
-
CY2011Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
189236000 USD
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80397000 USD
CY2011Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1724000 USD
CY2011Q2 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129010000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19704000 USD
CY2010Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15440000 USD
CY2010Q4 us-gaap Inventory Net
InventoryNet
15832000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5441000 USD
CY2010Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2149000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
58566000 USD
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3146000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6125000 USD
CY2010Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21908000 USD
CY2010Q4 us-gaap Goodwill
Goodwill
33416000 USD
CY2010Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1276000 USD
CY2010Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
360000 USD
us-gaap Interest Expense
InterestExpense
386000 USD
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2010Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
187893000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-83442000 USD
CY2010Q4 us-gaap Assets
Assets
124797000 USD
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4925000 USD
CY2010Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
451000 USD
CY2010Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
578000 USD
CY2010Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4693000 USD
CY2010Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
649000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11296000 USD
CY2010Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18009000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
954000 USD
CY2010Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
4290000 USD
CY2010Q4 us-gaap Liabilities
Liabilities
34549000 USD
CY2010 us-gaap Commitments And Contingencies2009
CommitmentsAndContingencies2009
-
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3896000 USD
CY2010Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124797000 USD
CY2010Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
273000 USD
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01 USD
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01 USD
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36057974 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28312467 shares
CY2010Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
281000 USD
CY2011Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01 USD
CY2011Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01 USD
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36217732 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28472225 shares
CY2011Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
362000 USD
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
361000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
96809000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
90248000 USD
us-gaap Revenues
Revenues
53456000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28301000 USD
us-gaap Gross Profit
GrossProfit
25155000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8449000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8561000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2395000 USD
us-gaap Restructuring Charges
RestructuringCharges
-28000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1310000 USD
us-gaap Operating Expenses
OperatingExpenses
20687000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4468000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-33000 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
12785000 USD
CY2011Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4271000 USD
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4206000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1128000 USD
CY2011Q2 us-gaap Restructuring Charges
RestructuringCharges
-28000 USD
CY2011Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
689000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
31000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-406000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-794000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3674000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
629000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29844000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28408000 shares
CY2011Q2 us-gaap Revenues
Revenues
27143000 USD
CY2011Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14358000 USD
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
10266000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2519000 USD
CY2011Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000 USD
CY2011Q2 us-gaap Interest Expense
InterestExpense
192000 USD
CY2011Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
16000 USD
CY2011Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-332000 USD
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-519000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2000000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
630000 USD
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05 USD
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05 USD
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28428000 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30187000 shares
CY2010Q2 us-gaap Revenues
Revenues
25905000 USD
CY2010Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13855000 USD
CY2010Q2 us-gaap Gross Profit
GrossProfit
12050000 USD
CY2010Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4191000 USD
CY2010Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3807000 USD
CY2010Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1102000 USD
CY2010Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2010Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
578000 USD
CY2010Q2 us-gaap Operating Expenses
OperatingExpenses
9678000 USD
CY2010Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2372000 USD
CY2010Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-81000 USD
CY2010Q2 us-gaap Interest Expense
InterestExpense
129000 USD
CY2010Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
7000 USD
CY2010Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-101000 USD
CY2010Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
125000 USD
CY2010Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2497000 USD
CY2010Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
615000 USD
CY2010Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06 USD
CY2010Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06 USD
CY2010Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29577000 shares
CY2010Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30044000 shares
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27373000 USD
us-gaap Revenues
Revenues
52205000 USD
us-gaap Gross Profit
GrossProfit
24832000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7998000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8068000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2309000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1109000 USD
us-gaap Operating Expenses
OperatingExpenses
19484000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
5348000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-107000 USD
us-gaap Interest Expense
InterestExpense
284000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
49000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-116000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5319000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1216000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29580000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29993000 shares
CY2011Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
CY2010Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
429000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
429000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
1370000 USD
CY2010Q2 us-gaap Net Income Loss
NetIncomeLoss
1882000 USD
us-gaap Net Income Loss
NetIncomeLoss
3045000 USD
us-gaap Net Income Loss
NetIncomeLoss
4103000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1210000 USD
us-gaap Depreciation
Depreciation
638000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
15000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
145000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
233000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1289000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2812000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
217000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
299000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-62000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1614000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
41000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-726000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2795000 USD
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-866000 USD
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-140000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-988000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
235000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
43000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
864000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
80000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
900000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
327000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
809000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2043000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-573000 USD
us-gaap Interest Paid
InterestPaid
310000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1267000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1233000 USD
us-gaap Depreciation
Depreciation
588000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
10000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
156000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-32000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
356000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
363000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-402000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
101000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-236000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6192000 USD
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-431000 USD
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-364000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1485000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2257000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2500000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4661000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-1751000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
179000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3733000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1071000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-869000 USD
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15719000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16588000 USD
us-gaap Interest Paid
InterestPaid
263000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1479000 USD

Files In Submission

Name View Source Status
0001193125-11-216296-index-headers.html Edgar Link pending
0001193125-11-216296-index.html Edgar Link pending
0001193125-11-216296.txt Edgar Link pending
0001193125-11-216296-xbrl.zip Edgar Link pending
d10q.htm Edgar Link pending
dex311.htm Edgar Link pending
dex312.htm Edgar Link pending
dex321.htm Edgar Link pending
dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
hbio-20110630.xml Edgar Link completed
hbio-20110630.xsd Edgar Link pending
hbio-20110630_cal.xml Edgar Link unprocessable
hbio-20110630_lab.xml Edgar Link unprocessable
hbio-20110630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending